Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3423699rdf:typepubmed:Citationlld:pubmed
pubmed-article:3423699lifeskim:mentionsumls-concept:C0024141lld:lifeskim
pubmed-article:3423699lifeskim:mentionsumls-concept:C2709248lld:lifeskim
pubmed-article:3423699lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:3423699pubmed:issue4lld:pubmed
pubmed-article:3423699pubmed:dateCreated1988-2-25lld:pubmed
pubmed-article:3423699pubmed:abstractTextIn the course of an ample study of collagen diseases carried out in the "N. Gh. Lupu" Institute of Internal Medicine--Bucharest over a long period, a group of 608 patients with systemic lupus erythematosus (SLE) hospitalized between 1974 and 1986 formed the object of the present study. Of these patients 18% presented pulmonary alterations due to SLE and 3.9% lung diseases of other etiology. The types of pulmonary involvement due to SLE were: pleurisy, interstitial pneumonia, diaphragmatic myopathy. Latent pulmonary damage could also be diagnosed in 8 patients. Most of the patients (94.1%) were females and had been hospitalized several times. Concomitantly with pulmonary damage other organ involvements have also been observed. Complex investigation of respiratory function performed in a selected group of patients revealed: restrictive syndrome, decrease of the gas transfer factor, increase of elastic recoil, hypoxemia on exercise. In most of the cases (92%) the pulmonary diseases had a chronic evolution. The treatment used was corticosteroids in 60% of the cases investigated.lld:pubmed
pubmed-article:3423699pubmed:languageenglld:pubmed
pubmed-article:3423699pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3423699pubmed:citationSubsetIMlld:pubmed
pubmed-article:3423699pubmed:statusMEDLINElld:pubmed
pubmed-article:3423699pubmed:issn0377-1202lld:pubmed
pubmed-article:3423699pubmed:authorpubmed-author:GheorghiuMMlld:pubmed
pubmed-article:3423699pubmed:authorpubmed-author:MateiIIlld:pubmed
pubmed-article:3423699pubmed:authorpubmed-author:TudorAAlld:pubmed
pubmed-article:3423699pubmed:authorpubmed-author:PuriceSSlld:pubmed
pubmed-article:3423699pubmed:authorpubmed-author:Balt?MMlld:pubmed
pubmed-article:3423699pubmed:authorpubmed-author:CojocaruMMlld:pubmed
pubmed-article:3423699pubmed:authorpubmed-author:PececCClld:pubmed
pubmed-article:3423699pubmed:issnTypePrintlld:pubmed
pubmed-article:3423699pubmed:volume25lld:pubmed
pubmed-article:3423699pubmed:ownerNLMlld:pubmed
pubmed-article:3423699pubmed:authorsCompleteYlld:pubmed
pubmed-article:3423699pubmed:pagination227-32lld:pubmed
pubmed-article:3423699pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3423699pubmed:meshHeadingpubmed-meshheading:3423699-...lld:pubmed
pubmed-article:3423699pubmed:meshHeadingpubmed-meshheading:3423699-...lld:pubmed
pubmed-article:3423699pubmed:meshHeadingpubmed-meshheading:3423699-...lld:pubmed
pubmed-article:3423699pubmed:meshHeadingpubmed-meshheading:3423699-...lld:pubmed
pubmed-article:3423699pubmed:meshHeadingpubmed-meshheading:3423699-...lld:pubmed
pubmed-article:3423699pubmed:meshHeadingpubmed-meshheading:3423699-...lld:pubmed
pubmed-article:3423699pubmed:meshHeadingpubmed-meshheading:3423699-...lld:pubmed
pubmed-article:3423699pubmed:meshHeadingpubmed-meshheading:3423699-...lld:pubmed
pubmed-article:3423699pubmed:articleTitlePulmonary involvement in systemic lupus erythematosus.lld:pubmed
pubmed-article:3423699pubmed:affiliationN. Gh. Lupu Institute of Internal Medicine, Bucharest, Romania.lld:pubmed
pubmed-article:3423699pubmed:publicationTypeJournal Articlelld:pubmed